RxDoctor Payments Data

Rushmi Reehal

Physician Assistant · Upland, CANPI 1780959742

Payments from drug & device makers

$5,232in general payments, 2019–2025

Across 216 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$734
  • UCB, Inc.$571
  • Genentech USA, Inc.$408
  • Inspire Medical Systems, Inc.$399
  • Novartis$374
  • Lilly USA, LLC$250
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,220100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,232 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
VumerityDiroximel Fumarate19$192,319
Kesimpta PenOfatumumab16$156,872
Avonex (4 Pack)Interferon Beta-1a13$103,991
Nurtec OdtRimegepant Sulfate38$57,473
Memantine Hcl236$8,798
Rasagiline Mesylate18$2,738
Carbidopa-Levodopa ErCarbidopa/Levodopa38$2,599
DilantinPhenytoin Sodium Extended11$2,469
Levetiracetam76$2,353
Entacapone12$2,113
Lamotrigine ErLamotrigine12$1,968
Gabapentin253$1,935
Carbidopa-LevodopaCarbidopa/Levodopa79$1,902
Divalproex Sodium24$1,792
Ropinirole Hcl71$1,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BiogenVumerity, Avonex (4 Pack)$226$296,31032 claims
PfizerNurtec Odt, Dilantin$77$59,94249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Upland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →